Cue Biopharma, Inc.
CUE
$0.768
-$0.0004-0.05%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 23.39M | 32.42M | 30.03M | 41.03M | 48.80M |
| Total Receivables | 945.00K | 3.15M | 1.85M | 1.40M | 1.70M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 805.00K | 1.68M | 2.02M | 2.24M | 955.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 25.14M | 37.26M | 33.90M | 44.67M | 51.45M |
|
|
|||||
| Total Current Assets | 25.14M | 37.26M | 33.90M | 44.67M | 51.45M |
| Net Property, Plant & Equipment | 4.84M | 4.60M | 5.48M | 6.33M | 7.12M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.21M | 2.95M | 2.95M | 2.96M | 2.96M |
| Total Assets | 32.19M | 44.81M | 42.33M | 53.95M | 61.53M |
|
|
|||||
| Total Accounts Payable | 2.82M | 6.47M | 3.91M | 3.92M | 3.50M |
| Total Accrued Expenses | 2.91M | 3.20M | 4.56M | 5.21M | 4.14M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.87M | 6.86M | 7.02M | 7.17M | 7.33M |
| Total Finance Division Other Current Liabilities | 85.00K | 259.00K | 976.00K | 1.79M | 2.11M |
| Total Other Current Liabilities | 85.00K | 259.00K | 976.00K | 1.79M | 2.11M |
| Total Current Liabilities | 13.69M | 16.79M | 16.46M | 18.09M | 17.08M |
|
|
|||||
| Total Current Liabilities | 13.69M | 16.79M | 16.46M | 18.09M | 17.08M |
| Long-Term Debt | -- | 1.33M | 2.29M | 3.24M | 4.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.00M | 1.33M | 1.96M | 2.58M | 3.16M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 14.69M | 19.44M | 20.71M | 23.91M | 24.45M |
|
|
|||||
| Common Stock & APIC | 359.36M | 357.73M | 345.33M | 343.58M | 338.28M |
| Retained Earnings | -341.86M | -332.37M | -323.71M | -313.54M | -301.19M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 17.50M | 25.37M | 21.62M | 30.04M | 37.09M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17.50M | 25.37M | 21.62M | 30.04M | 37.09M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 17.50M | 25.37M | 21.62M | 30.04M | 37.09M |
|
|
|||||